We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+20.73%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$498B
AUM Growth
+$25.7B
Cap. Flow
-$8.9B
Cap. Flow %
-1.79%
Top 10 Hldgs %
16.86%
Holding
2,648
New
135
Increased
1,180
Reduced
817
Closed
125

Sector Composition

Rank Sector Weight
1 Healthcare 18.56%
2 Consumer Discretionary 15.28%
3 Financials 14.93%
4 Technology 13.43%
5 Communication Services 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZION icon
1276
Zions Bancorporation
ZION
$10.5B
$12M ﹤0.01%
386,473
+1,200
+0.3% +$34.1K
GNRC icon
1277
Generac Holdings
GNRC
$12.8B
$11.8M ﹤0.01%
324,455
+13,600
+4% +$492K
WFBI
1278
DELISTED
WashingtonFirst Bankshares Inc
WFBI
$11.8M ﹤0.01%
501,304
+19,805
+4% +$450K
ACAT
1279
DELISTED
Arctic Cat Inc
ACAT
$11.7M ﹤0.01%
753,393
-54,252
-7% -$847K
LEG icon
1280
Leggett & Platt
LEG
$1.32B
$11.6M ﹤0.01%
255,136
+9,700
+4% +$499K
AXE
1281
DELISTED
Anixter International Inc
AXE
$11.5M ﹤0.01%
178,080
-390
-0.2% -$23.5K
TBPH icon
1282
Theravance Biopharma
TBPH
$878M
$11.4M ﹤0.01%
315,323
+104,560
+50% +$2.91M
APTI
1283
DELISTED
Apptio, Inc. Class A Common Stock
APTI
$11.4M ﹤0.01%
+526,000
New +$11.5M
NUS icon
1284
Nu Skin
NUS
$236M
$11.3M ﹤0.01%
175,105
+48,300
+38% +$2.72M
AJRD
1285
DELISTED
Aerojet Rocketdyne Holdings
AJRD
$11.3M ﹤0.01%
642,796
+51,400
+9% +$931K
AOS icon
1286
A.O. Smith
AOS
$8.49B
$11.3M ﹤0.01%
228,494
VASC
1287
DELISTED
Vascular Solutions Inc
VASC
$11.2M ﹤0.01%
231,780
-2,240
-1% -$104K
MNTA
1288
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$11.1M ﹤0.01%
950,164
-1,700
-0.2% -$20K
AIZ icon
1289
Assurant
AIZ
$13.9B
$11M ﹤0.01%
119,675
+900
+0.8% +$78.7K
SCL icon
1290
Stepan Co
SCL
$1.48B
$11M ﹤0.01%
151,488
+13,600
+10% +$914K
TMUSP
1291
DELISTED
T-Mobile US, Inc.5.50% Mandatory Convertible Preferred Stock, Series A
TMUSP
$11M ﹤0.01%
141,289
-1,505
-1% -$116K
TPH
1292
DELISTED
Tri Pointe Homes
TPH
$11M ﹤0.01%
831,560
-181,000
-18% -$2.39M
OB
1293
DELISTED
Onebeacon Insurance Group Ltd
OB
$10.9M ﹤0.01%
764,842
+28,700
+4% +$405K
PPBI
1294
DELISTED
Pacific Premier Bancorp
PPBI
$10.8M ﹤0.01%
+408,570
New +$10.6M
GIII icon
1295
G-III Apparel Group
GIII
$1.43B
$10.7M ﹤0.01%
365,919
-615
-0.2% -$24.1K
PRAA icon
1296
PRA Group
PRAA
$762M
$10.7M ﹤0.01%
308,370
+7,200
+2% +$212K
IQV icon
1297
IQVIA
IQV
$39.8B
$10.6M ﹤0.01%
130,357
-2,613
-2% -$198K
PAHC icon
1298
Phibro Animal Health
PAHC
$1.38B
$10.6M ﹤0.01%
388,390
-3,990
-1% -$90.2K
LECO icon
1299
Lincoln Electric
LECO
$15.5B
$10.6M ﹤0.01%
168,500
+5,360
+3% +$334K
PII icon
1300
Polaris
PII
$3.91B
$10.5M ﹤0.01%
135,920
-6,365
-4% -$553K

Similar funds

T. Rowe Price Associates's Q3 2016 Portfolio in Review

As of Q3 2016, T. Rowe Price Associates held 2,648 positions worth $498B, up 5.4% from $472B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

T. Rowe Price Associates's Q3 2016 filing shows 135 new, 1,180 increased, 817 reduced and 125 closed positions. Its largest new stake was Fortive: 55,770,886 shares worth $1.79B. The largest sale was TotalEnergies, an estimated $8.15B.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q3 2016 buy was Fortive: 55,770,886 shares worth $1.79B.
  • T. Rowe Price Associates added most to PayPal in Q3 2016, an estimated $1.64B increase.
  • T. Rowe Price Associates's biggest Q3 2016 reduction was TotalEnergies, cutting an estimated $8.15B.
  • T. Rowe Price Associates fully exited TYCO INTL PLC COM SHS (IRL) in Q3 2016, selling an estimated $1.77B.
  • T. Rowe Price Associates's ten largest holdings make up 17% of its $498B portfolio in Q3 2016.
  • T. Rowe Price Associates opened 135 new positions and closed 125 in Q3 2016.
  • T. Rowe Price Associates's portfolio value rose 5.4% quarter-over-quarter to $498B.

Based on T. Rowe Price Associates's 13F filing for Q3 2016, filed 14 Nov 2016.